Precision Biosciences (DTIL) Cash & Equivalents Growth (3y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -51.77% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 24.73% |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -28.55% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 13.33% |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -16.07% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 21.66% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -8.88% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 36.53% |
| 10 | Precision Biosciences | 171.70 Mn | 70.52 Mn | - | -14.35% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.35% |
| Dec 31, 2025 | -16.39% |
| Sep 30, 2025 | -40.41% |
| Jun 30, 2025 | -30.34% |
| Mar 31, 2025 | -12.74% |
| Dec 31, 2024 | -15.75% |
| Sep 30, 2024 | -14.94% |
| Jun 30, 2024 | -10.77% |
| Mar 31, 2024 | -10.70% |
| Dec 31, 2023 | 9.12% |
| Sep 30, 2023 | 5.48% |
| Jun 30, 2023 | 2.79% |
| Mar 31, 2023 | 0.85% |
| Dec 31, 2022 | 1.58% |
| Sep 30, 2022 | 0.93% |
| Jun 30, 2022 | -6.61% |
| Mar 31, 2022 | 2.16% |
| Dec 31, 2021 | 11.66% |
| Jun 30, 2021 | 11.54% |
| Mar 31, 2021 | 59.42% |